BioMarin Q3 Revenue Rises on Amicus Acquisition, Adjusted EPS Beats
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using…
Story updates
09:22:53 PM UTC
SquawkNews
BioMarin reported third-quarter 2026 revenue of $1.025 billion, up 32% year over year, and a GAAP net loss of $123 million. Non-GAAP diluted EPS was $0.23. The company lowered its full-year revenue and adjusted EPS guidance, citing order-timing uncertainty and charges related to two acquired progra…
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using…